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EXECUTIVE SUMMARY 
This report summarises the activities undertaken by the Fish Health Unit (FHU) of the Marine 
Institute (MI) in 2018 and 2019. The services of the FHU, undertaken on behalf of the State, 
are largely driven by European and national legislation on aquatic animal health. European 
Council Directive 2006/88/EC on animal health requirements for aquaculture animals lays 
down rules for the control of aquatic animal health within the EU. The directive is enacted in 
Irish Law by Statutory Instrument (SI) 261 of 2008. The MI is the Competent Authority (CA) 
responsible for implementation of aquatic animal health regulation in Ireland as described in 
these statutes.  
 
Aquatic animal health regulations in SI 261 of 2008 apply to finfish farms, shellfish farms, and 
put and take fisheries, and require that such aquaculture production businesses (APBs) obtain 
a Fish Health Authorisation (FHA) from the CA prior to operation. To receive an FHA, APBs 
must submit a fish health management plan (FHMP) to the CA for review and approval. The 
plan addresses, amongst other things, how aquatic animal health will be maintained, and 
diseases controlled, along with the mandatory conditions for record keeping and reporting to 
the CA. In addition to issuing FHAs to APBs, the CA conducts regular health surveillance of fish 
and shellfish farms. The CA is also responsible for regulating the movement of aquatic animals 
within Ireland and during import or export to and from the state.   
 
The MI hosts the National Reference Laboratories (NRLs) for finfish, mollusc and crustacean 
health. Testing conducted by the NRLs directly supports the implementation of the aquatic 
animal health controls in Ireland. NRL staff are also actively engaged in applied research to 
continually address disease diagnosis, treatment and management issues. 
 
This is the first published report of the activities associated with the functioning of the FHU. 
The aim of the report is to provide all stakeholders with an insight of the role the MI FHU plays 
in the application of aquatic animal health regulations. Through the publication of this report, 
the MI hopes to build a greater understanding of the issues relating to aquatic animal health 
in Ireland with a view to increasing engagement with all stakeholders. 
 
Fish Health Authorisations. During 2018 and 2019, the CA maintained fish health 
authorisations (FHAs) for 456 APBs involved in the production of fish or shellfish. The majority 
(319) of these APBs were associated with shellfish farming. In addition, the CA maintained 
FHAs for 64 put and take fisheries. In total, 16 new FHAs were issued to APBs during the two-
year period.   
Health Surveillance. A key feature of aquatic animal health control is implementation of 
effective surveillance programmes for early detection of health issues coupled with 
inspection to ensure APB compliance with regulations.  As part of a risk-based surveillance 
scheme, Department of Agriculture Food and the Marine (DAFM) Veterinary Inspectors (VIs) 
and FHU staff undertook 384 (191 in 2018 and 193 in 2019) inspections of FHA holders in 
 Ireland under the direction of the CA. These inspections resulted in one compliance notice 
being served to an oyster producer in 2018 for a continued failure to maintain mandatory 
records. Targeted surveillance was carried out for diseases of national importance. This 
involved sampling aquatic animals from representative sites and laboratory testing for 
identified pathogens in the NRLs. Based on this testing, existing disease-free status was 
maintained for diseases listed as notifiable in EU directive 2006/88/EC.  
Aquatic Animal Movements. In order to prevent the introduction or spread of diseases 
movements of aquatic animals are controlled by the CA. Movements must be approved in 
advance. Approval is given depending on the health status in the originating and receiving 
sites which is checked by the CA on a case-by-case basis. The CA approved 2,205 movements 
of molluscan shellfish, principally oysters, in 2018 and 2019 combined. These approvals 
included national movements, imports and exports. To facilitate exports, health certification 
was provided for 552 individual consignments of molluscs requiring physical inspection on 
111 occasions. The CA approved 210 movements of salmon and salmon ova (eggs). To 
facilitate exports, health certification was provided for 108 individual consignments of salmon 
or salmon ova. In addition, the CA approved 827 movements associated with the importation 
of ornamental aquatic animals into Ireland.  
Disease notifications and outbreaks. In May 2019, an isolated outbreak of koi herpesvirus 
disease (KHVD) occurred in an enclosed garden pond in in the Midlands. KHVD is listed as a 
notifiable disease in EU directive 2006/88/EC and Ireland is declared free of this disease. The 
outbreak was contained, fish culled, and the pond disinfected under the supervision of the 
CA. These control measures allowed Ireland to maintain disease free status for KHV.   No other 
diseases listed as notifiable were reported in Ireland in 2018 and 2019. There were, however, 
notable simultaneous outbreaks of koi sleepy disease in two angling venues in Co. Cork in 
April 2018. This was the first recorded outbreak of this disease in Ireland outside of an 
enclosed garden pond. Both outbreaks of koi sleepy disease were successfully contained 
through cross-agency action with Inland Fisheries Ireland and no further spread of disease 
was detected. There was a further outbreak of crayfish plague in the river Barrow in August 
2018.  The presence of crayfish plague was first detected in this river system in 2017. Crayfish 
plague is listed as a notifiable disease by World Health Organisation for Animal Health (OIE) 
but not in Council Directive 2006/88/EC). Crayfish Plague was also confirmed in new sites on 
the river Al in Co. Westmeath 2018 and in the River Maigue in Co. Limerick and in the River 
Slate in Co. Kildare in 2019. These further outbreaks of crayfish plague highlight an increasing 
spread of this disease in Ireland.  In September 2018, an outbreak of oyster herpesvirus 1 
microvariant (OsHV-1µVar) was confirmed at a production site in Poulnasherry Bay. 
Previously this bay was listed as disease free for oyster herpes virus under national measures 
implemented under article 43 of Directive 2006/88/EC.  
In summary, fish health inspection and monitoring activities undertaken in 2018 and 2019 
demonstrate a high level of compliance with statutory requirements in EU directive 
2006/88/EC and associated national legislation. Furthermore, the continued implementation 
of statutory controls by state agencies in Ireland and with the support of all stakeholders 
ensured a high health status for aquatic animals in Ireland was maintained in 2018 and 2019.  
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1 INTRODUCTION  
This report describes the activities undertaken by the Marine Institute (MI) Fish Health Unit 
(FHU) in 2018 and 2019 to deliver its responsibilities in the area of aquatic animal health under 
EU Council Directive 2006/88/EC and Statutory Instrument (SI) 261 of 2008 on behalf of the 
State. The activities of the FHU is delivered through two complementary services, that of the 
Competent Authority (CA) which regulates aquatic animal movements and health 
management; and the National Reference Laboratories (NRLs) for fish and shellfish diseases, 
which conducts standardised testing and applied research to support the mission of the CA. 
The purpose of this report is to provide all stakeholders with an improved understanding of 
the operations of the MI in this area of work, and the findings encountered by the FHU in 
2018 and 2019.  MI activities associated with the control of sea lice on salmon farms is not 
included in this report and is reported separately. (Sea Lice Report 2018) (Sea Lice Report 
2019)  2 REGULATORY BACKGROUND AND FHU RESPONSIBILITIES  2.1 European and National Regulation  
The FHU is the CA responsible for the implementation of aquatic animal health legislation in 
Ireland. The primary legislation in this regard is EU Council Directive 2006/88/EC. Published 
in 2006, the directive provides detailed rules on animal health requirements for aquaculture 
animals and products thereof, and on the prevention and control of certain diseases in aquatic 
animals. Directive 2006/88/EC was enacted in Irish Law in SI 261 of 2008 (as amended). The 
Council directive and associated national legislation provides a comprehensive risk-based 
approach to aquatic animal health management. Amongst other conditions, detailed rules 
and controls for aquatic animal health are given for the following areas: 
• Authorisation and registration of aquaculture production businesses (APBs); 
• Fish health surveillance; 
• Control of the movement of aquatic animals;  
• Disease notification and control 
The CA office in the FHU of the MI is responsible for the overall implementation of these 
controls in Ireland. 
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2.2 Authorisation and Registration of Aquaculture Production Businesses (APBs)  
All aquaculture production businesses (APBs), put and take fisheries, plants processing round 
(i.e. ungutted) fish, and specialist transporters of aquatic animals must register with the CA. 
The CA issues a fish health authorisation (FHA) once it is satisfied that the establishment 
meets all relevant regulatory fish health requirements. As part of the authorisation process, 
each APB must produce a Fish Health Management Plan (FHMP). A FHMP plan requires APBs 
to identify biosecurity measures relevant to their operation and demonstrate how it will 
comply with regulatory animal health requirements. The FHMP is approved by the CA. A 
register of authorised establishments is available on the FHU website (APB Register). In 
addition, importers of cold-water ornamental aquatic animals to closed facilities that do not 
discharge to the environment must register with the CA but are not required to hold a fish 
health authorisation. 
 2.3 Disease Notification and Control  
A fundamental element of the EU Council Directive 2006/88/EC is the requirements for APBs 
to monitor the health of their animals and to notify the CA on the presence or suspected 
presence of a disease listed in Annex IV of the directive. In the event of detection of a 
notifiable disease, the directive provides specific details on the obligations of the member 
state, through the CA, to report the outbreak to the EU and take measures to prevent the 
spread of the disease within member states and the EU. 
 
In addition, over and above the regulatory reporting requirements, notification schemes exist 
in Ireland for increased mortalities in aquatic animals present in APBs in both the oyster and 
salmon aquaculture sectors. These schemes are voluntary and are currently facilitated and 
monitored by the CA and NRLs in the FHU. These reporting schemes are described further in 
the relevant mortality reporting sections in this report for each of these aquaculture sectors.  
 2.4 Aquatic Animal Health Surveillance  
 
A key requirement of fish health controls under EU Council Directive 2006/88/EC is for 
member states to implement an active health surveillance programme. This programme is 
based primarily on inspection of APBs supported by targeted surveillance for specific diseases. 
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The frequency of the health surveillance inspections is risk-based and is determined on the 
likelihood of disease introduction or spread at individual sites. Generally, high-risk sites are 
inspected annually, medium risk sites every two years and low risk sites every four years. The 
major factors for determining the risk of introduction and spread of disease, the criteria by 
which sites are categorized for inspection frequency, is the number of movements of aquatic 
animals in and out of the site and the proximity to other sites in the production area. To 
implement the health surveillance inspection programme, DAFM veterinary inspectors (VIs) 
conduct on-the-ground site inspections and health visits at aquaculture sites under the 
supervision of the CA. In addition, targeted surveillance is carried out for certain diseases for 
which Ireland is declared free, either on a countrywide basis or in identified zones. This 
involves testing susceptible aquatic animals for specific disease pathogens using test methods 
recognised in EU regulation or in the World Organisation for Animal Health (OIE) Manual of 
Diagnostic Tests for Aquatic Animals. 
 
In addition to the health surveillance programme implemented by the CA, APBs are required 
in 2006/88/EC to undertake their own health surveillance, using Private Veterinary 
Practitioners (PVPs) where appropriate for the aquaculture production system. As well as 
advising APB operators directly on aquatic animal health issues, PVPs undertaking this 
surveillance are required to report immediately the suspicion of notifiable or unexplained 
emerging diseases to the CA. This industry-based surveillance forms a critical part of the 
overall health surveillance programme in Ireland and elsewhere in Europe.    
 2.5 Control of the Movement of Aquatic Animals   
Directive 2006/88/EC and SI 261 of 2008 provide detailed rules on the control of the 
movement of aquatic animals between aquaculture sites to protect the health status of the 
receiving aquaculture site. Any movement of aquaculture animals from one APB to another 
for farming or restocking purposes requires approval by the CA prior to that movement 
occurring. Other movements of aquatic animals may also require approval. Online 
applications to move aquatic animals are facilitated through the MI Fish Health Website.    
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2.6 Internal (national) Movements  
Movements of aquaculture animals within Ireland may only occur between authorised APBs. 
An application for approval of such movements must occur at least 72 hours prior to the 
intended movement. Each application is assessed by the CA considering the following details 
where relevant:  
• The health status of the zones of origin and destination. (The originating area must 
have at least the same or better health status as the final destination). 
• The susceptibility to disease of the species moved and at the receiving site. 
• Whether or not there are clinically diseased animals or unresolved mortalities at the 
origin site. 
• Veterinary inspection reports. 
• Any other factors relevant to aquatic animal health. 
 
 
Figure 1. Specialised transport wellboat for moving salmon between sites. Such movements require approval by 
the CA office in the Marine Institute and strict biosecurity measures are applied to prevent potential spread of 
aquatic pathogens. 
 2.7 Imports and Exports within the EU  
Any cross-border movement of live aquaculture animals that will be re-immersed in the 
aquatic environment must be notified to the CA in the receiving country via the EU’s Trade 
Control and Expert System (TRACES). TRACES is a web-based veterinary certification tool used 
by the European Union for controlling the import and export of all live animals and animal 
products within and without its borders. Approved imports are reconciled with the 
corresponding TRACES certificate from the country of origin by the CA. TRACES certificates 
are, in-turn, generated by the CA for exports originating from Irish APBs. On many occasions, 
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a TRACES notification is sufficient for the CA to approve an import into Ireland. However, for 
movements of susceptible or vector species between areas subject to disease surveillance 
programmes, full health certification and inspection within 72 hours prior to departure may 
be required. In such cases, inspection and health certification for export is performed on the 
ground by Department of Agriculture Food and the Marine (DAFM) VIs at the request of the 
CA. 
 2.8 Competent Authority Office Operations  
The CA office is responsible for delivery of all tasks associated with the implementation of 
aquatic animal health controls in Ireland. To deliver this programme the MI works closely with 
DAFM VIs who undertake on the ground inspections of APBs on a regionalised basis. A Service 
Level Agreement is in place between the MI and DAFM veterinary services to ensure 
inspections are delivered to agreed protocols and standards. The CA Office maintains a quality 
management system which was first certified by the National Standards Authority of Ireland 
(NSAI) in 2014 and transitioned to the requirements of ISO 9001:2015 which the CA are now 
certified to. This commitment to quality has enabled the CA Office to ensure that best 
operational practices are adhered to. Under this certification scheme delivery of the work 
programme is audited independently by NSAI on an annual basis. In 2018 and 2019, the CA 
office successfully passed the annual audit visits by the NSAI, as it has every year since initial 
certification in 2014.  
 2.9 National Reference Laboratories  
The National Reference Laboratories (NRLs) for aquatic animal health in Fish, Molluscs and 
Crustaceans in Ireland reside in the FHU in the MI. The NRLs form part of a network of 
reference laboratories in EU member states under the direction of the relevant EU Reference 
Laboratory. The roles of the NRLs are set out in Annex VI part II of EU Council Directive 
2006/88/EC. Most importantly, the NRLs provide the CA with testing services for the 
notifiable aquatic animal diseases listed in EU Council Directive 2006/88/EC and other 
diseases of national importance using internationally recognised and standardised methods. 
Tests used to detect the major diseases of concern in the directive and of national importance 
to Ireland are accredited to ISO 17025 standards. Accreditation is awarded by the Irish 
National Accreditation Board (INAB). The MI passed its annual ISO 17025 surveillance 
inspection in 2018 and 2019.  
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Figure 2.    Delivery of regulatory programmes for aquatic animal health in Ireland is a collaborative approach between the competent authority, NRLs 
and DAFM veterinary services.  
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2.10 Significant Aquaculture Sectors in Ireland  
 
Aquaculture is a significant economic activity in Ireland and in 2019 primary aquaculture 
production was worth €172 million BIM The Business of Seafood 2019. The primary products 
were salmon (€110 million), oysters (€44 million) and mussel (€14 million) with other fish (€2 
million) and shellfish (€2 million) species making up the rest of the production. In addition to 
aquaculture production, significant industries exist around put and take fisheries (angling) 
and the trade in ornamental aquatic animals that are also subject to control under EU Council 
Directive 2006/88/EC.  
 
 
Figure 3. Salmon (top) and Pacific oyster (bottom) production are the two largest aquaculture activities in Ireland 
and much of the work of the FHU is directed to application of legislation and control of aquatic animal health in 
these two sectors. 3 MOLLUSCAN SHELLFISH ACTIVITIES   3.1 Fish Health Authorisations (FHAs)  
In 2018 and 2019, the CA maintained 319 FHAs for shellfish APBs. These were divided 
between APBs producing Pacific oysters (54%), mussels (32%), multiple species (13%) and 
other species. During 2018 and 2019, 16 new authorisations were issued, and 24 
authorisations were revoked. Revocations of all FHAs that occurred in 2018 and 2019 were 
due to business closures, not violations of FHA conditions.  
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 3.2 Shellfish Health Surveillance Programme Inspections  
There is a relatively high frequency of animal movements associated with the majority of APBs 
producing Pacific oysters in Ireland. Consequently, APBs producing Pacific oysters are 
generally categorised as ‘medium risk’ sites and are therefore inspected every two years. 
Conversely, APBs producing mussels and other shellfish species are associated with fewer 
movements of animals and are therefore categorised as ‘low risk’ site and are generally 
inspected every four years. This inspection frequency may increase at individual sites where 
ongoing compliance issues are identified. In 2018 and 2019, 258 shellfish APBs were inspected 
as part of the annual surveillance programmes (Table 1). Minor non-compliances were 
detected during 81 inspections. These were primarily associated with failure to keep certain 
records. Seven inspections were associated with medium non-compliances which, in all cases, 
were triggered by continuing lack of record keeping over two successive inspections. One 
inspection was associated with a serious non-compliance based on a continuous and ongoing 
lack of any record keeping by the operator. In this case, the operator was issued with a 
compliance notice requiring them to comply with all requirements associated with their FHA 
and were re-inspected to ensure compliance.   
 
Table 1. Shellfish Health Surveillance Inspections in 2018 & 19 and associated non-compliance findings.  
Ye
ar
 Inspection Type No. Inspected 
in 2018  
No. of APBs inspected with non-compliances  
(% of FHAs inspected) 
 
Minor Medium Serious 
20
18
 
Pacific oysters 86 30 (35) 4 (5) 1 (<1) 
Mussels 29 6 (21) 0 (0) 0 
Multiple species 15 4 (27) 1 (7) 0 
Other 1 0 (0) 1 (100) 0 
Total 131 40 (31) 6 (5) 1 (<1) 
20
19
 
Pacific oysters 78 27 (35) 1 (1) 0 
Mussels 21 6 (29) 0 0 
Multiple species 20 6 (30) 0 0 
Other 3 2 (67) 0 0 
Total 127 41 (33) 1 (<1) 0 
Minor non-compliance – Minor shortfalls in record keeping. Minor housekeeping issues 
Medium non-compliance – Ongoing and repeated issues with record keeping or housekeeping issue 
Serious non-compliance – Operator has failed in his duties to an extent that the health status of bay or country may be 
affected (e.g., failure to inform CA of movements of shell or failure to report mortalities). This designation may also be used 
where there has been a continued disregard of minor or medium non-compliances identified in previous inspections. A serious 
non-compliance will normally result in in a compliance notice being issued. Failure to implement the compliance notice within 
the specified time limit can result in a revocation of the FHA.     
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3.3 Targeted Surveillance   
During 2018 and 2019, targeted surveillance continued for a number of shellfish diseases 
listed in EU Council Directive 2006/88/EC and those covered under national measures 
specifically applicable for Ireland. Specific monitoring was undertaken to maintain disease 
free status for two mollusc diseases, namely Bonamia ostreae and OsHV-1µVar. Bonamia 
ostreae is a listed disease in EU Council Directive 2006/88/EC that affects native oysters 
(Ostrea edulis) and is caused by a haplosporidia protozoan parasite. The only active native 
oyster fishery in Ireland that is recognised to be free from B. ostreae is Tralee Bay. A sample 
of 150 native oysters from Tralee Bay was tested for the presence of B. ostreae in both 2018 
and 2019 by microscopic examination.  Results confirmed that the site remains free from the 
presence of the parasite.  
At the beginning of 2018, six areas in Ireland were declared free from OsHV-1µVar. This virus 
generally infects juvenile Pacific oysters (seed and spat) and can cause significant mortalities 
in this population.  OsHV-1µVar is not a listed disease agent in Directive 2006/88/EC, however, 
it is controlled under national measures for Ireland.  Hence, the FHU monitors Pacific oyster 
growing areas for its presence or absence (aka disease free status).  This allows Ireland to 
place restrictions on oysters moving in and out of these disease free bays. Targeted 
surveillance testing of 30 animals was conducted for the presence of OSHV-1 µVar in each bay 
declared disease free in 2018. This targeted surveillance demonstrated that the 6 areas were 
free from the virus. However, in September 2018, a separately reported oyster mortality 
event in Poulnasherry Bay was confirmed to be caused by OsHV-1µVar. Previously, this 
production area was designated OsHV-1µVar disease free. The EU commission (DG SANTE) 
was informed of the outbreak on 26th September 2018 and Poulnasherry Bay was removed 
from the list of OsHV-1µVar disease free areas in Ireland.  All the production areas now 
designated as OsHV-1µVar disease free in Ireland are shown in Figure 4. All these five areas 
were tested for the presence of the virus during 2019 and laboratory analysis demonstrated 
that all areas remained free of OsHV-1µVar. 
In addition to targeted surveillance for B. ostreae and OsHV-1 µVar, fifteen bays were 
screened in both 2018 and 2019 for general pathology by histological examination. No 
significant pathology was associated with this screening. 
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Figure 4.  Oyster growing areas (compartments) in Ireland designated free of oyster herpesvirus (Os-HV-1 
µVar) at the end of 2019. In 2018, Poulnasherry Bay was confirmed as a OsHV-1 µVar positive site and was 
removed from the list of disease free sites in Ireland. 
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3.4 Shellfish Movements   3.4.1 Internal (national) Movements  
In total, over 2018 and 2019 the CA approved 777 movements of molluscan shellfish within 
Ireland. Most of these shellfish movements (751) were associated with the trade in Pacific 
oysters reflecting both the size and nature of Pacific oyster culture in Ireland.   
 3.4.2 Imports and Exports within the EU  
The number of international movements of shellfish approved by the CA in 2018 and 2019 
are shown in Table 2 below. Overall, in the two years, over 1.3 billion seed oysters were 
imported into Ireland in 682 approved movements. Most of these importations were from 
France. This highlights the reliance of the Irish oyster industry on supply of seed from France 
and the importance of the health status of the oyster seed originating from France. 
 
Table 2. National and International Movements of Shellfish Approved by the Competent Authority of the 
Marine Institute in 2018 and 2019 
Ye
ar
 
Species 
No. national approvals 
issued 
(weight in tonnes or No. 
in millions) 
No. import approvals 
issued 
(weight in tonnes or 
No. in millions) 
No. export approval 
issued 
(weight in tonnes or 
No. in millions) 
20
18
 
Pacific oyster 320 (2,068 T) 50 (549 T) 278 (1,729 T) 
Pacific oyster seed 38 (26.7 M) 337 (664.7m) 13 (15 M) 
Mussel 10 (1,101 T) 3 (538 T) 7 (49.34 T) 
Mussel seed 4 (36.4 T) 2 240 T) 6 (348 T) 
Total movements 372 392 304 
20
19
 
Pacific oyster 370 (2,554 T) 44 (398 T) 309 (2,024 T) 
Pacific oyster seed 23 (35.5 M) 345 (677 M) 6 (4 M) 
Mussel 5 (465 T) 2 (203 T) 12 (74 T) 
Mussel seed 7 (124 T) 3 (609 T) 11 (370 T) 
Total movements 405 394 338 
 
For most mollusc movements into and out of Ireland, a TRACES notification is sufficient to 
allow movement as the molluscs are moving to an area of equivalent or lesser health status 
to that in the bay of origin. TRACES notifications are monitored and approved by the CA office. 
To facilitate shellfish exports, in 2018 and 2019 757 applications were processed and 
notifications posted on TRACES by the CA. In addition, 114 physical inspections by DAFM VIs 
and FHU staff was required to sign health certificates. It should be noted that a movement 
approval issued by the CA can often cover more than one consignment of molluscs and 
 
Page | 15 
therefore the number of notifications posted on TRACES is greater than the number of 
movement approvals issued for exports by the CA.   
 3.5 Shellfish Disease Notifications   3.5.1 Mortality reporting   
Oyster producers are required to keep details of all increased mortalities. Where mortalities 
at a given point in the production cycle are significantly above those expected under 
prevailing conditions, mortalities are notified to the CA. For Pacific oyster related mortalities, 
reporting trigger levels have been introduced: 
• Seed and spat – report at mortalities of 30% or above 
• Half-grown and adults – report at mortalities of 10% or above 
In 2018, reports of increased mortalities associated with seed and spat oysters were received 
from 16 APBs operating in seven different bays. Mortalities associated with half-grown and 
adult oysters were reported from 26 APBs operating in 14 different bays. In 2019, reports of 
increased mortalities associated with seed and spat oysters were received from 15 APBs 
operating in 9 different bays. Mortalities associated with half-grown and adult oysters were 
reported from 28 APBs operating in 16 different bays (Table 3). Over the two years, laboratory 
investigations were completed on 18 samples associated with mortality in oyster spat and 
seed and OsHV-1µVar was detected in seven samples.  The endemic bacterial pathogen of 
oysters, V. aestuarianus was also detected in seven of these samples. V. aestuarianus was 
further detected in 31 of 34 samples associated with increased mortality in half-grown or 
adult oysters.  
 
Mortality reporting and associated laboratory investigations indicated a significant increase 
in mortality events associated with V. aestuarianus in both 2018 and 2019 compared with the 
previous two years.  However, mortality events associated with V. aestuarianus in the either 
2018 or 2019 did not reach the peak recorded mortalities that occurred in 2015. The number 
of bays recording mortalities were similar in 2018 and 2019. However, it was notable that 
mortality events in 2019 impacted bays with a larger production of oyster compared with 
those impacted in 2018.  V. aestuarianus associated mortalities cause a severe economic 
impact on the oyster industry. V. aestuarianus is not a listed disease in EU Council Directive 
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2006/88/EC nor is it controlled by national measures in Ireland. The cause of the increased 
mortalities in 2018 and 2019 compared with 2016 and 2017 are unclear. However, it is 
recognised that factors influencing the extent of oyster mortalities are multifactorial and links 
to several environmental factors are possible.   
 
In 2019, bacteria belonging to the Vibrio splendidus clade were also co-isolated with potential 
pathogens during mortality events in both spat and adults. The potential involvement of 
Vibrios belonging to the V. splendidus clade during mortalities has been described in France 
since the late 1990s and whilst they have been detected on several occasions in Ireland the 
evidence for their involvement in mortality events in 2019 is stronger than previously 
observed. Further investigation of the potential role of the V. splendidus clade on oyster 
mortalities is warranted.   
 
In 2018 and 2019, mortality events associated with OsHV-1µVar were less significant than 
those associated with V. aestuarianus infections. However, OsHV-1µVar infection can cause 
significant mortality in seed and spat oysters and remains economically devastating on an 
individual APB basis.  Despite this, there is increasing evidence that some oysters produced in 
French hatcheries in recent years may have an increased resistance to the virus. There is also 
practical evidence from industry that improved management procedures have been adopted 
that have reduced the impact of this virus in Irish oyster production.  It is now clear that 
infection with V. aestuarianus is the more significant challenge to the industry, compared to 
infections associated OsHV-1Var infection.  
Table 3. Mortality Reports for Pacific Oysters received by the Competent Authority in the Marine 
Institute in 2018 & 2019 
ye
ar
 Age Class No Bays 
reporting 
mortality 
No. 
Mortality 
reports 
No. of 
samples 
received 
Primary Pathogen Detected 
OsHV-1µVar V. aestuarianus 
20
18
 Spat/Seed 7 16 8 5 4 
Half Grown/Adult 14 26 16 0 15 
20
19
 Spat 9 15 10 2 3 
Half Grown/Adult 16 28 18 0 16 
 
No mortality or disease events were reported to the CA for other molluscan shellfish species 
in 2018 and 2019. 
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Figure 5. Histopathology associated with the two major pathogens causing disease in Pacific oysters.  
Haematoxylin and eosin stains of (A) Sinus and mantle pathology associated with Vibrio aestuarianus infection 
and (B). Haemocytic infiltration of the connective tissue associated with the presence of oyster herpes virus. 
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4 SALMON FARMING ACTIVITIES  
Atlantic salmon production is the largest aquaculture activity in Ireland by value. In 2019, it is 
estimated that salmon production was worth €110 million at the point of first sale. Salmon 
are usually farmed in two stages. First, the salmon are hatched from eggs and raised in land-
based freshwater tanks. When they are 12 to 18 months old the juvenile salmon, called 
smolts, are transferred to floating sea cages or net pens anchored in sheltered bays along the 
coast. For fish health purposes the term smolt is considered to relate to salmon that have 
undergone the physiological changes required to adapt to the marine setting through the 
process of smoltification and are ready to transfer to sea. Once in sea cages the salmon are 
then held for another 12 to 24 months, when they are harvested for processing. This 
production cycle influences where health surveillance is targeted in the salmon aquaculture 
sector.   
 
 
 
Figure 6. Life cycle of Atlantic salmon. Salmon have a juvenile freshwater stage and an adult seawater stage. This 
life cycle determines how salmon aquaculture production is performed and therefore how the Competent 
Authority organises health surveillance activities for this aquaculture sector in Ireland.  
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 4.1 Fish Health Authorisations for Salmon Sites   
During 2018 and 2019 a total of 57 production sites held a FHA related to salmon production 
in Ireland. Of these sites, 47 were operational in 2018. This included 22 freshwater/hatchery 
sites and 25 marine farm sites. Fifty-three sites were operational in 2019, 23 of these were 
freshwater /hatchery sites and 30 marine farm sites. 4.2 Salmon Health Surveillance   4.2.1 Inspections   
All marine production sites and most land-based freshwater sites including hatchery sites are 
designated as high-risk facilities for the purposes of the health surveillance programme. These 
high-risk sites are therefore inspected annually. In 2018, all operational marine sites (25) and 
16 freshwater sites were inspected as part of the annual health surveillance programme. In 
2019, all operational marine sites (30) and 21 freshwater sites were inspected as part of the 
annual health surveillance programme (Table 4.). 
Minor non-compliances, primarily associated with failure to keep fully completed records, 
were observed during 25 of inspections undertaken in 2018 and 2019. These non-compliances 
included: 
 
• Sites where records of fish movements etc. were maintained but were not readily 
available onsite on the day of inspection. At all of these sites records were supplied 
subsequently to the day of inspection; 
• instances where well boat arrival logs were not maintained on site but were 
subsequently made available; 
• records of disinfectant usage not fully maintained; 
• Changes to the type of disinfectant used not recorded.  
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Table 4. Health Surveillance Inspections on Salmon Farms by DAFM Veterinary Inspectors on Behalf of the 
Competent Authority Office of the Marine Institute in 2018/19  
ye
ar
 Inspection Type 
No. FHAs 
active in 
2018/19 
No. 
Inspected 
(%) 
No. of APBs inspected with non-
compliances (%) 
Minor (%) Medium (%) Serious (%) 
20
18
 
Marine Sites 25 25 (100) 15 (60) 0 0 
Freshwater sites 22 16 (73) 3 (19) 0 0 
Total 47 41 (87) 18 (44) 0 0 
20
19
 
Marine Sites 30 30 (100) - 0 0 
Freshwater sites 23 21 (91) 7 (33) 0 0 
Total 53 51 (96) 7 (13) 0 0 
Minor non-compliance – Minor shortfalls in record keeping. Minor housekeeping issues 
Medium non-compliance – Ongoing and repeated issues with record keeping or housekeeping issue 
Serious non-compliance – Operator has failed in his duties to an extent that the health status of bay or country may be 
affected. E.g. failure to inform CA of movements of fish or failure to report mortalities. This designation may also be used 
where there has been a continued disregard of minor or medium non-compliances identified in previous inspections. A serious 
non-compliance will normally result in in a compliance notice being issued. Failure to implement the compliance notice within 
the specified time limit can result in a revocation of the FHA.     
 4.2.2 Targeted Surveillance   
Ireland is declared free of all diseases listed as notifiable in EU Council Directive 2006/88/EC 
for which salmonid species are susceptible. In addition, under national measures described in 
EU 2010/221/EU, Ireland is declared free from bacterial kidney disease (BKD), gyrodactylosis 
cause by Gyrodactylus salaris (GS) and spring viremia of carp (SVC). In 2018 and 2019, Ireland 
continued to implement a targeted surveillance programme to demonstrate disease freedom 
for a number of pathogens affecting, or potentially affecting, salmon.  During this targeted 
surveillance, 26 samples consisting of a total of 757 fish were tested in 2018 and 30 samples 
consisting of 850 fish were tested in 2019. None of the pathogens targeted during this 
surveillance were detected. In addition to the targeted pathogen surveillance, these samples 
were subject to general bacteriological and histological screening and no significant health 
findings were identified. Therefore, during 2018 and 2019 this targeted surveillance 
programme did not detect any evidence of the presence of EU listed diseases or diseases 
controlled under national measures in salmon.  
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Figure 7.  Inspection of authorised salmon site by DAFM veterinary inspector 
 4.3 Salmon Movements   4.3.1 Internal (national) Movements  
In 2018 and 2019, the CA office approved 148 movements of salmon and salmon ova and 
gametes within Ireland. These movements included approval to move up to 21.3 million 
salmon ova and gametes, up to 17.7 million fish from freshwater sites includes fish 
transferring to marine sites, and up to 3.3 million salmon between marine sites for on growing 
or use as broodstock from marine sites (Table 5.). 
 4.3.2 Imports and Exports within the EU 
 
During 2018 and 2019, nine imports of salmon ova (4.1 million) were authorised by the CA. 
Fifteen exports of salmon ova (20.7 million) and 20 exports of smolts and pre-smolts (2.4 
million) were approved by the CA.  To facilitate the export movements, health certification 
was provided for 108 individual consignments of salmon and salmon ova prior to export from 
Irish APBs. It should be noted that a movement approval can often cover more than one 
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consignment. However, each consignment must be visually inspected and certified before 
export.  
Table 5. Salmon Movements Approved by the Competent Authority Office of the Marine Institute in 2018 
and 2019 
ye
ar
 
Life Cycle Stage 
Movement 
No. Internal 
movements  
(millions) 
No. Imports 
(millions) 
No. Exports 
(millions) 
20
18
 
Ova  7 (10.7)1 4 (2.4) 8 (9.4) 
Pre-smolts 20 (3.3) - 9 (1.5) 
Smolts3 35 (5.8) - 11 (0.9) 
On-growing (marine sites) 13 (1.9)   
Total 75 (21.7) 4 28 
20
19
 
Ova  6 (10.6)2 5 (1.7) 7 (11.3) 
Pre-smolt 12 (2.6) - 3 (0.4) 
Smolts3 36 (6.1) - 11 (0.6) 
On-growing (marine sites) 19 (1.4) - - 
Total 73 (20.7) 9 21 
1 including 6 million gametes. 
2 Including 8 million gametes 
3 For fish health purposes smolts are considered to be salmon that have undergone the physiological changes 
required to adapt to the marine setting through the process of smoltification and are ready to transfer to sea for 
ongrowing.   
 
In addition, the CA approved 178 applications for importations of dead ungutted salmon 
into Ireland for further food processing.  
 4.4 Disease Notifications   4.4.1 Mortality reporting  
EU Council Directive 2006/88/EC requires APBs to immediately inform the CA of the suspicion 
and /or confirmation of disease listed in the directive. In 2018 and 2019, there were no 
reports of diseases listed in EU Council Directive 2006/88/EC from Irish salmon aquaculture 
sites.  
 
There is no regulatory requirement in fish health regulations to report incidents of diseases 
that are not listed as notifiable in EU Directive 2006/88/EC to the CA. However, salmon 
producers operating in marine sites in Ireland participate in a voluntary programme to inform 
the CA of increased mortalities over certain trigger levels.  These are, on a weekly basis: 
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• 1% for fish >750g in weight 
• 1.5% for fish <750g in weight 
 
In 2018, the CA office received a total of 41 weekly reports of increased mortalities for marine 
salmon sites.  These represented nine discreet events ranging from 1 to 10 weeks each in 
duration. These occurred at eight separate sites.  (Table 6). Principle causes of mortality, as 
diagnosed by private veterinary practitioners engaged by the APBs, are recorded in Table 6. 
In addition, for the first two mortality events recorded in 2018 cardiomyopathy syndrome 
(CMS) caused by piscine myocarditis virus (PMCV) was confirmed by diagnostic testing in the 
NRL. Principle infections associated with the mortality events were amoebic gill disease (AGD) 
caused by Neoparamoeba perurans, pancreas disease (PD) caused by salmon alphavirus, CMS 
and one event involving an outbreak of piscirickettsiosis caused by the bacterium 
Piscirickettsia salmonis. Mortality was often associated with multifactorial causes and 
included non-infectious causes such as phytoplankton blooms and jellyfish. The peak weekly 
mortality recorded at any site in 2018 was 11.55%. This occurred during the longest running 
event at any site, which lasted for ten weeks between June and August. The reasons for this 
mortality event were multifactorial including infectious health issues (AGD and PD) which 
were exacerbated by highly significant impacts from jellyfish swarms. The next highest weekly 
mortality rate recorded during a five-week event at a single site was 8.55%. This was not 
associated with infectious disease but was reported to be associated with extensive blooms 
of phytoplankton at a site during November and December of 2018. Overall, for the 41 weekly 
mortality reports the mean weekly percentage mortality rate was 3.53% ranging from 1.2 to 
11.55% for any given week. 
 
In 2019, 66 weekly reports of mortality were received by the CA, representing 20 distinct 
mortality events ranging from 1 – 10 weeks in duration. These occurred in ten separate sites. 
The peak weekly mortality rate of 13.1 % occurred during a five-week event in July and 
August. This mortality event was primarily associated with gill disorders along with failed 
smolts. Failed smolts are salmon that do not feed properly after being transferred to sea. This 
causes progressive weight loss and poor condition. The condition of these fish will be 
compromised and they are more prone to health issues. The causes of failed smolt syndrome 
are complex, multifactorial and often not fully identified  (Failed Smolt Syndrome).  Failed 
smolts were reported as a feature of three mortality events in 2019. Samples from mortality 
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events were obtained by the NRL for confirmatory testing on seven occasions.  Principle 
infections associated with the mortality events were AGD, PD and CMS. Furunculosis, caused 
by the bacterium Aeromonas salmonicida, occurred in two instances, while in four cases later 
in the year, mortalities were associated with piscirickettsiosis. Again, as in 2018, mortality was 
often associated with multifactorial causes in 2019, and phytoplankton blooms and jellyfish, 
in addition to failed smolts, were the principle reported non-infectious causes of mortality.  
In addition to reported mortalities on salmon farms, in February of 2019 the CA was informed 
of mortalities during well boat transfer of juvenile salmon from a freshwater site to a marine 
farm site for on growing. Approximately 60,000 of 208,000 fish moved were reported to have 
died during transport. Following a subsequent inspection of the fish by a DAFM VI the cause 
of mortality was inconclusive, but the extent of mortality was likely exacerbated by a 
prolonged transit time due to bad weather preventing unloading of the fish at the destination 
site.  
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Table 6. Mortality Reports for Salmon Marine Sites submitted to the Competent Authority Office of the Marine Institute in 2018 
 Year Event no. Duration 
(weeks) 
Month(s) Average weekly % 
mortality (Range)  
Reported Primary Cause(s)1 
AGD / gill 
disorders 
PD  CMS Pisci-
rickettsiosis 
Failed smolts Furunculosis Other2    
20
18
 
13  6 Mar-Apr 2.0 (1.6-2.3)   *     
23  7  Mar-Apr 2.9 (1.3-4.3)   *     
3  1  June 1.6  *      
4  1  July 1.2 *  *     
5 2 July 3.8 (2.2-5.5)  *      
6 10  Jun-Aug 4.1 (2.2-11.5) * *     * 
7 7  Aug-Sept 4.39 (2.2-7.4) *      * 
8  2 Nov 1.2 (1.3-1.3 )    *    
9  5 Nov-Dec  5.0 (1.5-8.3)       * 
20
19
 
1 3 Jan 3.7 (2.8-4.5)  *      
2 1 April 6.4  *   *  * 
3 1 May 1.3  *      
4 5 July-Aug 9.2 (4.58-13.1) *    *   
5 5 July-Aug 3.2 (1.6-4.0) * *   * * * 
6 1 Aug 2.5  *      * 
7 1 Aug 3.1       * 
8 10 Aug-Oct 4.2 (1.7-7.9) *  *    * 
9 1 Sept 2.4 *      * 
10 8 Aug-Oct 2.9 (2.2-5.6) *  *    * 
11 4 Sept-Oct 5.7 (3.2-8.4)       * 
12 6 Sept-Oct 4.9 (3.3-9.9) *      * 
13 6 Sept-Oct 3.0 (1.2-6.1) *  *    * 
14 4 Oct 1.4 (1.4-1.4) *   *   * 
15 4 Oct 1.5 (1.2-1.5)    *    
16 1 Nov 3.06 *      * 
17 1 Nov 1.6    *    
18 2 Dec 1.3 (1.3 – 1.4)      *  
19 1 Dec 1.4  *      
20 1 Dec 1.2   * *    
1reported primary causes as diagnosed by private veterinary practitioner.  2 other causes including non-infectious causes e.g. most commonly phytoplankton blooms or jellyfish swarms.  
3 two separate locations within the same bay
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4.5 The Use of Cleaner Fish on Salmon Farms   
Sea lice infestation of salmon is a recognised fish health issue during salmon production. 
Cleaner fish are being increasingly used throughout the salmon farming sector worldwide as 
a biological control for sea lice infestations. The use of cleaner fish reduces the use of physical 
and chemical treatments to control sea lice. The two species of fish commonly utilised in the 
role are lumpfish and several varieties of wrasse. Cleaner fish may be cultured specifically for 
the purpose or caught from the wild. Generally, in Ireland, lumpfish originate from cultured 
sources while wrasse are caught from the wild.  However, significant technical efforts are 
being made by the salmon industry to culture wrasse for use as cleaner fish.    
 
To prevent any potential spread of fish pathogens to salmon sites by the introduction of 
cleaner fish the CA continues to work with industry to develop protocols to reduce the risk.  
A risk analysis has been completed and control procedures have been developed.  The risk 
analysis and management plans are available in the Farmed Salmonid Handbook. As part of these 
protocols extensive fish health screening is undertaken on a bay-by-bay basis prior to fishing 
for wrasse. Prior to movement of cleaner fish onto a salmon farm a veterinary report is 
required to demonstrate that the fish are clinically healthy.  In 2018 and 2019, the CA 
approved 68 movements of wrasse (involving up to a maximum 732,800 fish), and 35 
movements of lumpfish (Approx. 604,800 fish) onto salmon sites for use as cleaner fish (Table 
7.)  These figures clearly demonstrate an increasing use of cleaner fish to control sea lice 
numbers of salmon aquaculture.  
 
Table 7. Cleaner fish Movements on to Salmon Farms Authorised by the Competent Authority Office of the 
Marine Institute in 2018 and 2019 for Sea Lice Control purposes 
Ye
ar
 species No. Internal movements 
(No. fish thousands) 
No. Imports  
(No. fish thousands) 
20
18
 Wrasse  28 (370.1) 0 
Lumpfish 8 (36.6) 6 (153.0) 
Lumpfish (ova) 0 2 (450.0) 
20
19
 Wrasse  40 (362.7) 0 
Lumpfish 9 (230.9) 12 (154.3) 
Lumpfish (ova) 0 3 (1,700.0) 
 
To facilitate movements of cleaner fish, in 2018, the NRL undertook fish health screening of 
420 wrasse from 8 bays and 450 lumpfish from production units while in 2019, 418 wrasse 
from 7 bays and 190 lumpfish from production units were tested. Fish were screened for viral 
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and bacterial pathogens as well as by histological examination for general health purposes. 
No significant health findings were associated with this screening and all movements of 
cleaner fish applied for were approved by the CA.  
 
 
Figure 8. – Lumpfish used as cleaner fish on marine salmon farms to control sea lice infestations. Cleaner fish 
are increasingly being used throughout the salmon farming sector worldwide as a biological control for sea lice 
infestations. The two species of fish commonly utilised in the role are lumpfish and several varieties of wrasse. 
 5 OTHER FINFISH AQUACULTURE PRODUCTION SITES  
In 2018 and 2019, there were 18 APBs producing trout (14) or perch (4) which have fish health 
authorisations to operate issued by the CA. This included one new FHA issued in 2018 for a 
newly opened perch fish farm. Of these sites, 12 were operational during 2018 and 2019.  
 5.1 Finfish (other than Salmon) Health Surveillance    
In 2018 and 2019, 19 health surveillance inspections were carried on trout and perch farms 
in Ireland (Table 8.). During those inspections only minor non-compliances relating to record 
keeping were identified.  
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Table 8. Health Surveillance in 2018 in finfish farms other than salmon by DAFM Veterinary Inspectors on 
Behalf of the Competent Authority  
Ye
ar
 Inspection 
Type 
No. sites 
active  
No. Inspected 
(%) 
No. of inspection with non –compliances by 
grade* 
Minor (%) Medium (%) Serious (%) 
20
18
 Trout 8 8 (100) 4 (50) 0 0 
Perch 1 1 (100) 0 0 0 
Total 9 9 (100) 4 (44) 0 0 
20
19
 Trout 8 8 (100) 2 (22) 0 0 
Perch 2 2 (100) - 0 0 
Total 10 10 (100) 2 (18) 0 0 
Minor non-compliance – Minor shortfalls in record keeping. Minor housekeeping issues 
Medium non-compliance – Ongoing and repeated issues with record keeping or housekeeping issue 
Serious non-compliance – Operator has failed in his duties to an extent that the health status of bay or country may be 
affected. E.g. failure to inform CA of movements of fish or failure to report mortalities. This designation may also be used 
where there has been a continued disregard of minor or medium non-compliances identified in previous inspections. A serious 
non-compliance will normally result in in a compliance notice being issued. Failure to implement the compliance notice within 
the specified time limit can result in a revocation of the FHA.     
 5.2 Finfish (other than Salmon) Movements   
Internal movements, imports and exports for trout and perch approved by the CA office in 2018 are 
shown in Table 9. 
Table 9. Finfish movements, other than salmon, approved by the Competent Authority office of the Marine 
Institute in 2018  
ye
ar
 Species  
Movement 
No. Internal movements 
(thousands) 
No. Imports  
(thousands) 
No. Exports  
(thousands) 
20
18
 Perch 1 (200) 0 0 
Trout 24 (1,200) 0 10 (4) 
Trout (ova) 1 (500)  7 (2,700) 0 
20
19
 Perch 3 (0.066) 0 0 
Trout 24 (1,400) 0 4 (2.5) 
Trout (ova) 2 (500) 7 (2,500) 0 
 
In addition to the movements of live fish shown in Table 9, the CA approved 305 applications 
for importation of un-gutted dead trout into Ireland for further food processing. 
  
 
Page | 29 
 6 PUT AND TAKE FISHERIES   
A put and take fishery is defined in EU Council Directive 2006/88/EC as “a pond or other 
installation where the population of fish are maintained only for recreational fishing by 
restocking with aquaculture animals.” In 2018 and 2019 there were 64 put and take fisheries 
with FHAs in Ireland. Three new FHAs was issued for a put and take fishery in during this 
period. During 2018 and 2019, the CA approved 503 movements of fish on to stocked fisheries 
in Ireland. Stocked fisheries include put and take fisheries. 
 
Given the enclosed nature of put and take fisheries and the low level of movement of fish to 
and from them, these operations present a low risk for the introduction and spread of disease. 
Given this low risk the CA has not undertaken any health surveillance inspections of put and 
take fisheries since 2016.  
 6.1 Disease Notifications  
In May 2018, the CA was informed of high numbers of carp mortalities in two coarse angling 
venues in County Cork. One of the venues was a public fishery in Cork City and over the course 
of the incident, approximately 1,000 carp died. In the second venue, a private fishery about 
10 km away from the location of the first outbreak approximately 300 carp died. Following 
laboratory analysis in the NRL, the causative agent of both outbreaks was determined as carp 
edema virus (CEV). CEV causes a disease commonly called koi sleepy disease although the 
disease virus is capable of infecting cyprinid species other than koi carp such as the case with 
the outbreaks in Cork. Infection with CEV is not a listed disease in EU Council Directive 
2006/88/EC but can cause very significant mortalities and rapid reporting and control is 
desirable. The disease is widespread in Europe but has previously only been detected once in 
Ireland in koi carp in a garden pond. Further genetic analysis undertaken in the NRL 
demonstrated that the virus in carp from both venues were similar to each other and fell 
within the genotype associated with common carp rather than Koi carp. This indicated that 
the infection was not a result of the release of Koi carp into the venues affected in 2018, which 
had been considered a possibility, and that the virus was likely to have come from the same 
origin.  In response to the mortalities, Inland Fisheries Ireland closed the fisheries for angling 
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and ensured disposal of the dead carp in approved facilities to prevent the risk of disease 
spreading. As a result of these actions no further spread of the disease was observed.  
Follow up investigations found no evidence of movements of fish between the two venues or 
movement of fish into them from elsewhere prior to the outbreak. A possible explanation for 
the outbreak is that the virus may have been introduced into one of the venues by an angler 
using contaminated equipment. This could also account for the apparent spread of disease 
between the two venues by the same route. This re-enforces the need for the consistent and 
thorough application of biosecurity measures at angling venues and adherence to check clean 
dry protocols for disinfecting angling equipment when moving between sites. 
 
No outbreaks of disease in angling venues were reported in Ireland in 2019. 
 
 
Figure 9. Disinfection of angling equipment between uses is a critical control measure to prevent the spread of 
disease between angling venues. 
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 7 ORNAMENTAL AQUATIC ANIMALS  
EU Council Directive 2006/88/EC defines an ornamental aquatic animal is defined as an 
“aquatic animal which is kept, reared, or placed on the market for ornamental purposes only.” 
Specific regulations are in place to control the risk of potential introduction or spread of 
disease associated with the trade of ornamental aquatic of disease. The level of control varies 
between tropical and cold-water animals with particular attention paid to cold-water 
ornamental animals given that they are capable of surviving in the Irish environment. All 
importers of ornamental finfish, mollusc and crustacean aquatic animals must register with 
the CA before importing fish. Details of requirements for importing ornamental aquatic 
animals in to Ireland are available on the Fish Health Website. During 2018 and 2019, 827 
consignments of ornamental aquatic animal imports were approved by the CA. The majority 
of these consignments were imported from the UK and contained multiple species of 
ornamental animals destined for several locations in Ireland including private individuals, as 
well as wholesale and retail establishments.   
 7.1 Disease Notifications  
In May of 2019, the CA was notified of mortalities of koi carp in a garden pond in the Midlands 
of Ireland. In response to the mortality reports, the FHU carried out a health visit on the 31st 
May and took samples from three moribund fish for analysis in the NRL. On the same day, the 
samples were analysed and were found to be presumptively positive for the presence of koi 
herpesvirus (KHV) by molecular screening methods allowing a suspicion of KHV disease 
(KHVD) to be declared. KHVD can be a devastating disease of carp and is associated with high 
mortalities. In this case 60% of the koi carp present died.  KHVD is listed as a notifiable disease 
in EU Council Directive 2006/88/EC and the island of Ireland was declared free of the disease 
after a targeted two-year surveillance programme completed in in 2013.  In this case once a 
suspicion of KHVD was declared, movement restrictions were placed on the site. The presence 
of KHV disease was subsequently confirmed by further molecular analysis using diagnostic 
procedures described in Commission Implementing Decision (EU) 2015/1554. The EU 
commission was informed of the confirmation of KHVD. On 15th June all koi carp remaining in 
the pond were culled and the pond was disinfected under the supervision of the CA.  
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Subsequent investigations indicated that the owner of the pond had personally imported koi 
carp from an establishment in England that was not certified KHV free. The owner had driven 
to England and collected the fish personally and thus by-passing regulatory import 
requirements. It is possible that this was the source of infection in the pond and ornamental 
fish keepers are reminded of the importance of complying with regulatory import 
requirements when sourcing koi carp and other ornamental fish. Detail of import 
requirements are on the FHU website.   
 8 NRL ACTIVITIES   
The NRLs provide laboratory testing services to support the implementation of aquatic animal 
health controls in Ireland. This involves supporting the health surveillance activities 
undertaken by the CA and PVP activities undertaken on behalf of APBs. The NRLs in the Marine 
Institute operate within a quality management system and the majority of tests utilised are 
accredited to ISO 17025 by the Irish National Accreditation Body (INAB). Testing is conducted 
using methods required by regulation or recommended in the OIE manual of diagnostic tests 
for aquatic animals. This ensures the results obtained during testing are reliable and robust 
as well as being fit for purpose.  
 8.1 Finfish NRL  
In total in 2018 and 2019, the NRL analysed 5,581 fish from 259 samples for a variety of 
purposes (Table 10). Analysis consisted of histopathological, virological, bacterial and 
molecular examinations undertaken as required by the relevant programme.   
 
Over the two years Eighty-nine percent of fish analysed in the NRL were associated with 
salmon farming (cleaner fish 30% and Atlantic salmon 59%) (Figure 10). This is reflective of 
the extent of salmon farming activities compared to other finfish aquaculture activities in 
Ireland and the extensive efforts placed on maintaining fish health within the salmon farming 
sector.  
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Table 10. Finfish samples tested by the National Reference Laboratory in 2018 and 2019 
Testing 
Programme 
Species 2018 2019 
No. of samples No. of fish No. of samples No. of fish 
 National 
Surveillance1 
Atlantic salmon 21 607 22 630 
trout (rainbow of brown) 5 150 7 150 
Cyprinids - - 1 30 
Mortality 
Investigations  
Carp 2 9 3 12 
Atlantic salmon 2 20 5 50 
wild Atlantic salmon -  3 3 
Health 
Checks  
  
  
  
Atlantic salmon 6 141 3 46 
coarse fish and stickleback 6 139 1 30 
Trout 1 26 - - 
carp - - 1 14 
Screening for 
cleaner fish 
movements 
wrasse 9 420 7 418 
lumpfish  3 450 3 190 
Private 
testing2 
Atlantic salmon (includes brood) 41 638 63 885 
lumpfish 13 123 6 54 
wrasse  2 20 - - 
Miscellaneous 10 14 2 2 
Research 
Projects 
Atlantic salmon 5 280 1 1 
  Miscellaneous - - 5 29 
Totals    126 3037 133 2544 
1 For diseases listed as notifiable in EU 2006/88 and of concern under national measures  
2 Testing requested by private companies and private veterinary practitioners  
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Figure 10.  Percentage of 5581 samples tested in the finfish NRL by species in 2018 and 2019. Almost 90% of 
samples analysed in the NRL was associated with salmon aquaculture (Atlantic salmon 59% and cleaner fish 
30%).   8.1.1 Significant findings from finfish NRL testing   
No agents responsible for diseases listed as notifiable in EU Council Directive 2006/88/EC or 
controlled under national measures in Ireland were detected during testing conducted by the 
NRL in 2018. Analysis by the NRL confirmed cases of koi sleepy disease caused by CEV was 
associated with two reports of carp mortalities. Further molecular analysis of the virus 
isolated from fish samples from both venues confirmed that the genotypes were consistent 
with that found in common carp (rather than Koi carp) and that the viruses probably 
originated form a common source. Analysis of salmon samples in 2018 the NRL confirmed the 
association of piscine myocarditis virus two incidents of reported mortalities in marine farms. 
The NRL also confirmed one case of Proliferative Kidney Disease, an endoparasitic disease of 
salmonid fish caused by the Myxosporean parasite Tetracapsuloides bryosalmonae was 
confirmed in a freshwater salmon production unit by analysis in the NRL.  
 
In 2019, molecular analysis in the NRL confirmed the presence of KHV in moribund koi carp 
sampled during an investigation of increased mortality in a private pond. Molecular analysis 
also detected CEV in these fish. Further details of this outbreak are provided in section 7.1 of 
this report.  The NRL also detected CEV in koi carp in a separate incident of mortality from a 
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private pond during July. The NRL confirmed gill damage and the presence of CMS or piscine 
orthoreovirus by histological examination or molecular analysis in samples associated with 
four incidents of salmon mortality in marine farms. Finally, in both 2018 and 2019, Yersinia 
ruckeri was detected in rainbow trout at a farm associated with persistent problems with 
enteric redmouth disease, the common name typically applied to Y. ruckeri infections.  
 
In June 2019, reports of morbidity and mortality were received in returning wild Atlantic 
salmon associated with a rash-like discolouration on the abdomen. Similar disease signs in 
returning salmon were also reported from Scotland and Norway at this time. In late June, 
samples were collected from a freshly dead salmon by FHU staff for analysis in the NRL. 
Samples were also provided to the NRL by Inlands Fisheries Ireland from two salmon post-
mortem, one in July and one in August. Despite extensive examination and investigation by 
the NRL no significant aetiological agents were identified. Laboratories in other countries that 
reported a similar condition in wild salmon were also unable to detect an infectious agent.  
The Marine Institute will continue to work with Inland Fisheries Ireland in 2020 to obtain 
samples from any further incidences and investigate morbidity and mortality in returning 
salmon in 2020.   
 8.2 Molluscan Shellfish NRL 
In 2018 and 2019, the NRL tested a total of 106 samples consisting of 3194 Pacific and native 
oysters (C. gigas and O. edulis) for a variety of programmes (Table 11). Testing consisted of 
general histology and bacteriology examination. In addition, targeted surveillance 
programmes were undertaken. These targeted direct detection of V. aestuarianus and OsHV-
1 µvar using molecular procedures and Bonamia ostrea using either cytology or molecular 
analysis as determined by the aims of the programme. 
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Table 11. Molluscan shellfish samples tested by the National Reference Laboratory in 2018  
Year  Programme Species No. of samples No of animals 
20
18
 
National Surveillance1  native oysters  2 150 
Pacific oysters  20 320 
Mortality report investigations Pacific oysters 24 698 
Diagnostic investigations  
 
native oysters 6 319 
Pacific oysters 1 30 
Research  Pacific oysters 2 120 
  Totals 55 1,637 
20
19
 
National Surveillance1  native oysters  2 300 
Pacific oysters  18 290 
Mortality report investigations Pacific oysters 28 878 
Diagnostic investigations  
 
native oysters 1 30 
Pacific oysters 2 39 
Research - - - 
  Totals 51 1557 
1 For diseases listed as notifiable in EU 2006/88 and under national measures (namely Bonamia ostreae, oyster herpesvirus-
1 uVar & emerging diseases).  
 
The most frequently detected pathogen during testing in 2018 and 2019 and which was 
always associated with mortality was V. aestuarianus, with 27 of the 47 samples tested 
containing the bacterium. In addition, V. aestuarianus was detected in five further samples 
alongside OsHV-1 µVar. V. aestuarianus was also detected in 23 of 49 samples tested in 2019 
(two in conjunction with OsHV-1 µVar. These results confirm the fact that V. aestuarianus 
infection in Pacific oysters is the most significant molluscan disease issue in Ireland.   
An interesting observation during testing in 2019 was the additional isolation of bacteria 
belonging to the Vibrio splendidus clade in five samples associated with mortality in both spat 
and adults. The potential involvement in mortalities of bacteria belonging to the V. splendidus 
clade has been described in France previously. Their role in the mortalities observed here 
remains unclear and warrants further investigation.   
 8.3 NRL Research and Projects   
In 2018 and 2019, the NRLs were involved in several research projects. In 2018, the NRL for 
crustacean diseases completed a significant project to assess the health status of velvet crab 
(Necora puber) stocks in three bays in Ireland with a focus on the prevalence of the parasite 
Paramarteilia sp. This project was undertaken in conjunction with the Fisheries and 
Ecosystem Advisory Services (FEAS) team in the Marine Institute following reports of a general 
decline of the velvet crab fishery. Initial work indicated high detection rates of the parasite 
Paramarteilia sp. in some populations. To determine the health status of velvet crabs in three 
important fisheries in Ireland 150 crabs from each site were subject to histopathological and 
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molecular analysis for the presence of parasites. Differences in the percentage of velvet crabs 
containing Paramarteilia sp. varied from fishery to fishery (Figure 11). Other parasite species 
most notably Haematodinium sp. were also detected.  
   
Figure 11. Percentage of velvet crabs containing Paramarteilia sp. in three fisheries in Ireland. 
 
While a significantly higher proportion of velvet crabs in the Galway Bay fishery contained 
Paramarteilia sp. compared to the other two fisheries an impact on health associated with 
this was not directly demonstrated. In general, the impact of the presence of Paramarteilia 
sp. and Haematodinium sp. on velvet crab health remains unclear. To further advance our 
understanding, the MI awarded a fellowship grant to GMIT for a 3-year study. This study 
commenced in late 2018 and the NRL is working closely with GMIT to support delivery of the 
project. The specific aims of this research are to investigate the extent to which micro parasite 
species are impacting crustacean health, with an emphasis on the effect of environmental 
conditions on the susceptibility of crustaceans and investigating transmission between 
crustacean species and reservoir hosts. The results from this study will be available in 2021. 
Within the area of salmon health, the NRL continues to work with UCD on an MI funded Cullen 
Fellowship aimed at developing a better understanding of piscine myocarditis virus (PMCV) 
which is responsible for cardiomyopathy syndrome (CMS). CMS is a significant disease 
affecting farmed Atlantic salmon and was first reported in Ireland in 2012. The number of 
clinical cases of CMS had increased in the following years, however, very little information is 
available on the prevalence of the virus in both farmed and wild fish. The principal aim of this 
fellowship is the development of improved diagnostic methods for CMS. Work in 2018 
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focussed on genetic diversity of PMCV present in Irish farmed salmon.  Results showed PMCV 
genotypes to be largely homogenous in Irish samples, showing little genetic diversity. The 
study further suggests that PMCV may have been introduced into Ireland in two waves, both 
coming from the southern part of PMCV's range in Norway. Evidence also indicates that either 
PMCV is evolving to become less virulent in Ireland or Irish Atlantic salmon are developing 
immunity or resistance to the disease.   
In 2019 the focus of the work expanded to cover a new strain of salmonid alphavirus. Using 
nanopore sequencing, the whole genome of a strain isolated from ballan wrasse in Ireland 
was sequenced and revealed to be a new subtype of the virus, SAV7. Nanopore sequencing 
was then used to sequence the genome of an Irish strain of PMCV in combination with 
Illumina sequencing. The whole genome sequences have revealed that a large amount of the 
virus’s genetic diversity lies outside the regions previously sequenced using traditional sanger 
sequencing, and a number of mutations, unique to Irish isolates, have been identified. The 
project will be completed in September 2020. 
The NRL also undertook work to support a DAFM funded project on Amoebic Disease of 
Salmon (ADIOS). This project is led by Galway Mayo Institute of Technology, and the project’s 
consortium includes National University of Ireland Galway, University College Dublin, MI, Fish 
Vet Group Ireland and several indigenous and foreign-based companies. The overall aim of 
the ADIOS project is to increase knowledge of host immune response in the Atlantic salmon-
amoebic gill disease complex, identifying potential biomarkers and developing preventative 
and curative measures to minimise occurrence of gill health issues. The project commenced 
in late 2017. The MI has a minor role in the project and provides laboratory support and 
testing to project partners. In 2018 and 2019, as part of the ADIOS project, the MI analysed 
gill and swab samples from 290 salmon for the presence of Neoparamoeba perurans, the 
causative agent of AGD. Results from the project will be published later in 2020.  
In the area of molluscan health, the NRL is a partner in a large multi-partner European funded 
research project aimed at preventing and mitigating farmed bivalve disease (VIVALDI) 
http://www.vivaldi-project.eu/. In 2018, the MI Shellfish NRL work primarily focused on 
developing management and mitigating factors for V. aestuarianus infections in Pacific 
oysters. Work to date clearly demonstrates that disease progression is complex. Multifactorial 
environmental conditions and site-specific factors play a fundamental role in driving disease 
outcomes. Therefore, specific across the board guidance on mitigating for the disease has 
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been difficult to develop. However, at some sites management practices were identified that 
may reduce mortalities. Further work during the year investigate the genetic diversity of 
OsHV-1µVar. In 2019, the MI activities focussed on the construction of a disease management 
and biosecurity manual. This process involved scientists, competent authorities and 
producers from across the major shellfish producing nations in Europe. Publication of the 
manual is anticipated in the in the second half of 2020. The project will end in early 2020 and 
a final conference for all stakeholders was held in Brest in France in November 2019 to 
present the outcomes from the project. VIVALDI  9 ADDITIONAL ACTIVITIES UNDERTAKEN BY THE FHU IN 2018 & 2019  9.1 European Commission Directorate-General for Health and Food Safety mission on implementation of the rules on Irish Aquaculture.  
In April 2018, Ireland was subject to a one-week long inspection on the implementation of 
the rules on bivalve mollusc aquaculture. This was conducted by the European Commission 
Directorate-General for Health and Food Safety DG (SANTE). This visit was part of a wider fact 
finding mission conducted in four of the major mollusc producing European Member States, 
namely, Ireland, Spain, Italy and France. The published report found that controls in Ireland 
were implemented to a high level and several areas of implementation were highlighted as 
examples of good practice.  9.2 Transboundary Surveillance Programme in Lough Foyle  
As a result of the long-standing negotiation of the international border in Lough Foyle, 
licences have not been issued for aquaculture activity in the Lough. This means that APBs 
operating in Lough Foyle cannot be authorised by the CA in Ireland. Despite this situation, in 
recent years, production of Pacific oysters in the Lough has grown to very significant levels.  
To evaluate the health status of oysters in Lough Foyle the FHU, in conjunction with DAERA 
and the Loughs Agency, established a 2-year disease surveillance programme in the Lough in 
late 2018.  In addition, the CA introduced measures aimed at preventing the movement of 
oysters from the Lough for on growing or relaying and only oysters going directly for 
consumption are permitted to be moved from the Lough. Monitoring is ongoing and results 
from the surveillance programme will be available in late 2020. 
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9.3 National Monitoring Programme for Crayfish Plague  
Aphanomyces astaci is a water mould that causes lethal crayfish plague in the white-clawed 
crayfish Austropotamobius pallipes which is the only crayfish species that is native to Ireland. 
Crayfish plague is believed to have originally entered Europe with the introduction of a non-
native North American species of crayfish, which are resistant to crayfish plague. Crayfish 
plague is listed as a notifiable disease by World Health Organisation for Animal Health (OIE) 
but not in Council Directive 2006/88/EC. The white-clawed crayfish is considered to be 
endangered and protected under the EU Habitats Directive EU Habitats Directive. However, 
in recent years, outbreaks of crayfish plague have occurred in Ireland. The first confirmed 
outbreak of crayfish plague in Ireland was recorded in the Erne catchment in 2015 although 
there is strong evidence to suggest there was an outbreak in 1987 in the rivers Boyne and 
Inny. Between 2015 and the end of 2018, crayfish plague was detected in six geographically 
distinct river catchments in Ireland with at least three different strains of A. astaci genotyped. 
This genetic diversity suggests there have been at least three separate introductions of the 
disease into Ireland. To prevent the spread of crayfish plague in Ireland water users should 
adhere to the check clean dry protocols.  
 
In 2018, the MI and the National Parks and Wildlife Service jointly introduced a 2-year national 
surveillance programme for crayfish plague in Ireland. Using environmental DNA (eDNA) as a 
surveillance method, the NRL for crustacean diseases analysed water samples from 84 sites 
(6 sites per catchment) in 14 water catchments. Aphanomyces astaci was detected in three 
of these catchments, indicating an active infection was in progress. In addition, an active 
outbreak of crayfish plague was identified following crayfish mortalities in the River Al in 
Athlone. Aphanomyces astaci was detected in both moribund crayfish and water samples 
taken from this river in 2018. In 2019, the second phase of water sampling using eDNA 
methodology was undertaken. Water samples were collected from an additional 84 sites in 
14 catchments.  Analysis of water samples for the presence of Aphanomyces astaci is on-going 
and will be completed by May 2020. Water samples collected in 2018 and 2019 will also be 
tested for the presence of DNA from non-native species. Non-native species selected for 
analysis will be based on species listed in the European Union (Invasive Alien Species) (Freshwater 
Crayfish) Regulations 2018 (SI 354/18).  In addition, water samples will also be examined for the 
presence of DNA from Cherax destructor (Yabby), Astacus Leptodactylus (Turkish crayfish) and 
Astacus astacus (Noble crayfish). To this end, work to develop a multiplex real-time PCR for 
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analysis was recently completed. Analysis of all samples collected in 2018 and 2019 will be 
analysed by June 2020 as part of a national monitoring programme. 
In addition to the national monitoring programme, the NRL detected Aphanomyces astaci in 
crayfish samples associated with four outbreaks of crayfish plague in 2018 and 2019. This 
included a further outbreak of plague in the river Barrow which was also affected in 2017 and 
outbreaks in new sites on the river Al in Athlone (2018), the River Maigue in Co. Limerick and 
the river Slate in Co. Kildare (2019). These further outbreaks of crayfish plague highlight an 
increasing spread of this disease in Ireland.    
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APPENDIX 1. ADDITIONAL SOURCES OF INFORMATION  
Information sources  
1. Marine Institute Fish Health website provides a range of information of aquatic animal 
health in Ireland. This includes  
• Information Leaflets on important diseases of aquatic animals 
• Requirements for Fish Health Authorisations   
• Registers of Authorised Aquaculture Businesses (APBs), Put and Take Fisheries, 
Approved Aquaculture Transporters and Authorised Processing Establishments in 
Ireland. (APBs Finfish) (APBs Molluscs) (Put & Take Fisheries) (Authorised 
Processing Establishment Register) (Approved Aquaculture Transporters) 
• Reporting Aquatic Animal Mortalities 
• Details for Importers of ornamental aquatic animals  
 
2. The Farmed Salmonid Handbook  provides a comprehensive manual on fish health for 
Ireland’s salmon and trout farming industry. It contains detailed and practical information 
on all aspects of fish stock care ranging from veterinary issues, environmental protection, 
feed & nutrition, treatments and current legislation. The Handbook was compiled by 
experts from both private and governmental organisations.  The handbook was launched 
in 2011. An updated version of the handbook was made available in July 2017 
3. European Union Reference Laboratory for fish and Crustacean Diseases is situated within 
the unit for Fish and Shellfish Diseases at DTU Aqua – National Institute of Aquatic 
Resources at the Technical University of Denmark. The functions and duties of the EURL 
are concerned with harmonizing diagnostic procedures for notifiable fish and crustacean 
diseases in Europe. The Unit for Fish and Shellfish Diseases at DTU Aqua has since 1994 
been designated as the EURL for fish diseases. From July 2018, the functions and duties 
were expanded to also include crustacean diseases.  
4. European Union Reference Laboratory for Mollusc Diseases is situated in IFREMER in 
France and is responsible for coordinating methods employed by EU Member States for 
diagnosing diseases of bivalve molluscs.  
5. World Organisation for Animal Health (OIE) Aquatic Animal Health Code 21st Edition, 
2019. The OIE Aquatic Animal Health Code provides standards for the improvement of 
aquatic animal health worldwide. It also includes standards for the welfare of farmed fish 
and use of antimicrobial agents in aquatic animals. The sanitary measures of the Aquatic 
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Code should be used by the Competent Authorities of importing and exporting countries 
for early detection, reporting and control of pathogenic agents in aquatic animals. 
6. World Organisation for Animal Health (OIE) OIE Manual of Diagnostic Tests for Aquatic 
Animals 7th Edition, 2016 . The manual provides a standardised approach to the diagnosis 
of the diseases listed in the Aquatic Code, to facilitate health certification for trade in 
aquatic animal products.  
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APPENDIX 3. EU Regulations and Statutory Instruments Relevant for Aquatic Animal Health in Ireland 
EU Council Directive 
2006/88/EC 
Animal Health requirements for aquaculture animals and products thereof, andprevention and control of certain diseases in aquatic animals. 
Commission 
Regulation (EC) No 
1251/2008/EC 
Conditions and certification requirements for the placing on the market and the import into the Community of aquaculture animals and products 
thereof and laying down a list of vector species. 
Commission Decision 
2010/221/EU 
This Decision gives Ireland protection from additional significant diseases affecting finfish, which are not listed in 2006/88/EC and which not 
present in Ireland. SVC, BKD, Gyrodactylus Salaris (GS)). 
Commission Decision 
2010/171/EC 
Established a targeted surveillance programme for koi herpes virus (KHV) to assess Ireland's status in relation to KHV (Ireland is currently Category 
III) and thereafter achieve Category I status (freedom). 
Commission Decision 
2011/187/EU 
This decision gives the approval of national measures for preventing the introduction of OsHV-1 µvar into certain areas of Ireland and the United 
Kingdom. 
Commission 
Regulation 
2011/350/EU 
Requirements for place consignments of Pacific oysters on the market in Member States. The main objective is to protect the areas which remain 
free of OsHV-1 µvar. This regulation repeals Commission Regulation 175/2010 
Commission 
Implementing 
Directive 2012/31/EU 
Commission Implementing Directive 2012/31/EU of 25 October 2012 amending Annex IV to Council Directive 2006/88/EC as regards the list of fish 
species susceptible to Viral haemorrhagic septicaemia and the deletion of the entry for Epizootic ulcerative syndrome 
Commission 
Implementing 
Decision 2013/706/EC 
Amending annex I to Decision 2009/177/EC declares disease-free status for Ireland for Koi herpes virus thereby giving the highest health status 
available in Europe with respect to this disease (Category I status as defined in Fish Health Directive 2006/88/EC).  
Commission 
Implementing 
Decision 
2016/1096/EC 
Amending Regulation (EC) No 1251/2008 as regards the requirements for placing on the market of consignments of certain fish species intended 
for the Member States or parts thereof with national measures for salmonid alphavirus (SAV). 
S.I. 261 of 2008 Council Directive 2006/88/EC was transposed into Irish Law by the European Communities (Health of Aquaculture Animals and Products) 
Regulations 2008. (SI No. 261 of 2008). This was subsequently amended in 2010 and 2011 (see amendment regulations below). 
S.I. No. 398 of 2010 These Regulations amend the European Communities (Health of Aquaculture Animals and Products) Regulations 2008 (S.I. No. 261 of 2008), to 
take account of developments at European Union level.  
S.I. No. 430 of 2011 
 
These Regulations amend the European Communities (Health of Aquaculture Animals and Products) Regulations 2008 (S.I. No. 261 of 2008) to give 
effect to new measures introduced by Commission Decision 2011/187/EU as regards the approval of national measures for preventing the 
introduction of ostreid herpesvirus 1 μvar (OsHV-1µVar). The Regulations provide for the establishment of national measures in relation to OsHV-1 
μvar, which will allow areas (bays) which are currently free of the virus to be protected in terms of trading with areas infected with OsHV- 1 μvar. 
S.I. No. 23 of 2015 European Communities (Health of Aquaculture Animals and Products) (Amendment) Regulations 2015. This Regulation amends Annex IV to Council 
Directive 2006/88/EC as regards infectious salmon anaemia (ISA) 
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APPENDIX 4. Notifiable Diseases Listed in Annex IV of EU Directive 2006/88   
Notifiable diseases are those listed in Part II, Annex IV of Council Directive 2006/88/EC, 
as amended. Directive 2006/88/EC classifies notifiable diseases into two categories. 
Each category has its own set of criteria for listing.  
Exotic Diseases - These are exotic to the European Community and have the potential 
for significant economic consequences in aquaculture or have potential to cause 
detrimental environmental effects to wild species if they occur in the European 
community.  
Exotic diseases listed as notifiable in Directive 2006/88/EC 
Fish Molluscs Crustacean 
 Epizootic haematopoietic 
necrosis (EHN) 
 Infection with Bonamia 
exitiosa  
 Taura syndrome 
  Infection with Perkinsus 
marinus  
 Yellowhead disease 
  Infection with Microcytosis 
mackini  
 
Non-exotic Diseases - These are present in some parts of the European Community 
and have either, the potential for significant economic consequences in aquaculture 
or the potential to cause detrimental environmental effects to wild species if they 
occur in regions where they are not currently found. 
Non-exotic diseases listed as notifiable in Directive 2006/88/EC 
Fish Molluscs Crustacean 
Infectious salmon anaemia 
(ISA) 
 Infection with Bonamia 
ostreae 
White spot disease 
Viral haemorrhagic 
Septicaemia (VHS) 
Infection with Marteilia 
refringens  
 
Infectious haematopoeitic 
necrosis (IHN) 
   
 Koi herpes virus (KHV) 
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Notifiable Diseases Listed Under National Measures for Ireland - In addition to the 
diseases listed above, Ireland is free of the following diseases for which we have 
applied national measures under Article 43 of Directive 2006/88/EC and enacted 
through Community legislation (Decision 2010/221/EU as amended).  
 
Diseases for which Ireland has implemented national measures 
Fish Molluscs 
Gyrodactylosis Oysters herpesvirus 1-µVar 
Spring viraemia of carp (SVC)   
Bacterial kidney disease   
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APPENDIX 5. List of all Marine Environment Health Series 
 
No. 1. Assessment of Water Quality Data from Kilkieran Bay, Co. Galway 
Evin McGovern, A. Rowe, B. McHugh, J. Costello, M. Bloxham, Conor Duffy, Eugene 
Nixon (2001). http://hdl.handle.net/10793/219 
 
No. 2. Trace metal and chlorinated hydrocarbon concentrations in shellfish from Irish 
waters, 1997-1999. Evin McGovern, A. Rowe, B. McHugh, J. Costello, M. Bloxham, 
Conor Duffy, Eugene Nixon (2001). http://hdl.handle.net/10793/220 
 
No. 3. The fate of oxytetracycline in the marine environment of a salmon cage farm. 
R. Coyne, P. Smith, Christopher Moriarity (2001). http://hdl.handle.net/10793/221 
 
No.4. Winter nutrient monitoring of the Western Irish Sea - 1990 to 2000 
Evin McGovern, Eileen Monaghan, M. Bloxham, A. Rowe, Conor Duffy, A. Quinn, 
Brendan McHugh, T. McMahon, M. Smyth, M. Naughton, M. McManus, Eugene 
Nixon (2002). http://hdl.handle.net/10793/222 
 
No.5. Monitoring of zebra mussels in the Shannon-Boyle navigation, other navigable 
regions and principal Irish lakes, 2000 & 2001 Dan Minchin, F. Lucy, M. Sullivan 
(2002). http://hdl.handle.net/10793/223 
 
No. 6. Monitoring of tributyl tin contamination in six marine inlets using biological 
indicators. Dan Minchin (2003). http://hdl.handle.net/10793/224 
 
No.7. Trace metal and chlorinated hydrocarbon concentrations in shellfish from Irish 
waters, 2000 Denise Glynn, Linda Tyrrell, Brendan McHugh, A. Rowe, Jim Costello, 
Evin McGovern (2003). http://hdl.handle.net/10793/225 
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No. 8. Trace metal and chlorinated hydrocarbon concentrations in various fish 
species, landed at selected Irish ports 1997-2000. Linda Tyrrell, Denise Glynn, A. 
Rowe, Brendan McHugh, Jim Costello, Conor Duffy, A. Quinn, M. Naughton, M. 
Bloxham, Eugene Nixon, Evin McGovern (2003). http://hdl.handle.net/10793/226 
 
No. 9. Environmental quality and carrying capacity for aquaculture in Mulroy Bay Co. 
Donegal. T. Telfor, K. Robinson (2003). http://hdl.handle.net/10793/228 
No.10. Trace metal and chlorinated hydrocarbon concentrations in shellfish from 
Irish waters, 2001. Denise Glynn, Linda Tyrrell, Brendan McHugh, A. Rowe, Eileen 
Monaghan, Jim Costello, Evin McGovern (2003). http://hdl.handle.net/10793/231 
 
No.11. The Irish coral task force and Atlantic coarl ecosystem study report on two 
deep-water coral conservation stakeholder workshops held in Galway in 2000 and 
2002 A. Grehan, R. Long, B. Deegan, M. O’Cinneide (2003). 
http://hdl.handle.net/10793/234 
 
No.12. The occurrence and risk assessment of the pesticide toxaphene in fish from 
Irish waters. (2003). Brendan McHugh, Denise Glynn, Eugene Nixon, Evin McGovern 
(2003). http://hdl.handle.net/10793/235 
 
No.13. Trace Metal and Chlorinated Hydrocarbon Concentrations in Various Fish 
Species Landed at Selected Irish Ports, (2001). Linda Tyrrell, Denise Glynn, Brendan 
McHugh, A. Rowe, Eileen Monaghan, Jim Costello, Evin McGovern (2003). 
http://hdl.handle.net/10793/237 
 
No.14. An epidemiological investigation of the re-emergence of pancreas. Disease in 
Irish farmed Atlantic Salmon (Salmo Salar L.) in 2002 M. F. McLoughlin, E. Peeler, K. 
L. Foyle, H. D. Rodger, D. O'Ceallachain, F. Geoghegan (2003). 
http://hdl.handle.net/10793/239 
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No.15. Salmon Mortalities at Inver Bay and Mc Swynes Bay Finfish Farms, County 
Donegal, Ireland during 2003. Margot Cronin, Caroline Cusack, Fiona Geoghegan, 
Dave Jackson, Evin McGovern, T. McMahon, Francis O'Beirn, M. O'Cinneide & Joe 
Silke (2004). http://hdl.handle.net/10793/241 
 
No.16. Trace Metal and Chlorinated Hydrocarbon Concentrations in Shellfish from 
Irish waters, (2002). Denise Glynn, Linda Tyrrell, Brendan McHugh, Eileen Monaghan, 
Jim Costello, Evin McGovern (2004). http://hdl.handle.net/10793/255 
 
No. 17. Review of the potential mechanization of kelp harvesting in Ireland 
Astrid Werner Stefan Kraan (2004). http://hdl.handle.net/10793/261 
 
No.18. Trace metal and chlorinated hydrocarbon concentrations in Various Fish 
species landed at selected Irish Port, 2002 Linda Tyrrell, Mary Twomey, Denise 
Glynn, Brendan McHugh, Eileen Joyce, Jim Costello, Evin McGovern 
(2004).http://hdl.handle.net/10793/260 
 
No.19. Proceedings of the 5th Irish Shellfish Safety Scientific Workshop (2005) 
http://hdl.handle.net/10793/259 
 
No. 20. Trace metal and chlorinated hydrocarbon concentrations in Various Fish 
Species landed at selected port 2003. Linda Tyrrell, Brendan McHugh, Denise Glynn, 
Mary Twomey, Eileen Joyce, Jim Costello, Evin McGovern (2005). 
http://hdl.handle.net/10793/229 
 
No.21. Karenia mikimotoi: An exceptional Dinoflagellate bloom in western Irish 
waters, Summer 2005. J. Silke, F. O’ Beirn and M. Cronin (2005). 
http://hdl.handle.net/10793/240 
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No. 22. Research on Pancreas Disease in Irish Farmed Salmon 2004/2005 - Current & 
Future Initiatives. Neil Ruane, H. Rodger, D. Graham, L. Foyle, A. Norris, J. Ratcliff, K. 
Murphy, S. Mitchell, C. Staples, H. Jewhurst, D. Todd, Fiona Geoghegan, M. 
O'Cinneide (2005). http://hdl.handle.net/10793/247 
 
No. 23. Proceedings of the 6th Irish Shellfish Safety Workshop, Galway, 1st 
December 2005 (2006). http://hdl.handle.net/10793/249 
 
No. 24. Guidelines for the assessment of dredge material for disposal in Irish waters. 
Margot Cronin, Evin McGovern, Terry McMahon, Rick Boelens, Marine Environment 
Consultant - Portroe, Nenagh, Co. Tipperary & Corresponding author (2006). 
http://hdl.handle.net/10793/251 
 
No. 25. Trace Metal Concentrations in Shellfish from Irish Waters, 2003. B. Boyle, 
Linda Tyrrell, Brendan McHugh, Eileen Joyce, Jim Costello, Denise Glynn, Evin 
McGovern (2006). http://hdl.handle.net/10793/252 
 
No. 26. Investigation into levels of dioxins, furans, polycholorinated biphenyls and 
brominated flame retardants in fishery produce in Ireland. ChristinaTlustos, Brendan 
McHugh, Iona Pratt, Linda Tyrrell, Evin McGovern (2006). 
http://hdl.handle.net/10793/254 
 
No. 27. Proceedings of the 7th Irish Shellfish Safety Workshop (2007. 
http://hdl.handle.net/10793/262 
 
No. 28. Isolation and purification of AZAs from naturally contaminated materials, and 
evaluation of their toxicological effects. Phillip Hess, Pearse McCarron, Nils 
Rehmann, Jane Kilcoyne, Terry McMahon, Gavin Ryan, Michael P. Ryan, Michael J. 
Twiner, Gregory J. Doucette, Masayuki Satake, Emiko Ito, Takeshi Yasumoto (2007). 
http://hdl.handle.net/10793/268 
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No. 29. Bonamia Ostrea in the native oyster Ostrea edulis: A Review. Sarah Culloty 
and Marie Mulcahy (2007). http://hdl.handle.net/10793/269 
 
No. 30. Infectious pancreatic Necrosis Virus and its Impact on the Irish Salmon 
Aquaculture and Wild Fish Sectors. Neil Ruane, Fiona Geoghegan, M. O’Cinneide 
(2007). http://hdl.handle.net/10793/270 
 
No. 31. Management recommendations for the sustainable exploitation of mussel 
seed in the Irish Sea. J. A. Maguire, T. Knights, G. Burnell, T. Crowe, Francis O’Beirn, 
D. McGrath, M. Ferns, N. McDonough, N. McQuaid, B. O’Connor, R. Doyle, C. Newell, 
R. Seed, A. Smaal, T. O’Carroll, L. Watson, J. Dennis, M. O’Cinneide (2007). 
http://hdl.handle.net/10793/271 
 
No. 32. Issues and recommendations for the development and regulation of marine 
aggregate extraction in the Irish sea Cathal O’Mahony, Gerry Sutton, Terry 
McMahon, Micheal O’Cinneide, Eugene Nixon (2008). 
http://hdl.handle.net/10793/272 
 
No. 33. Proceedings of the 8th Irish Shellfish Safety Workshop (2008) 
http://hdl.handle.net/10793/273 
 
No. 34. Pancreas disease in farmed salmon – health management and investigations 
at Irish farm sites. 2005 – 2008. http://hdl.handle.net/10793/267  
No. 35. Pilot water quality monitoring station in Dublin Bay north bank monitoring 
station (NBMS) MATSIS Project Part 1 Garvan O’Donnell, Eileen Joyce, Shane 
O’Boyle, Evin McGovern (2008). http://hdl.handle.net/10793/274 
No. 36. Irish Sea Marine Aggregate Initiative (IMAGIN), Technical Synthesis Report 
Gerry Sutton. (2009). http://hdl.handle.net/10793/277 
 
No. 37. Proceedings of the 9th Irish Shellfish Safety Workshop (2009) 
http://hdl.handle.net/10793/28 
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No. 38. An Assessment of Dangerous Substances in Water Framework Directive 
Transitional and Coastal Waters: 2007 – 2009.  McGovern, E., Cronin, M., Joyce, E., 
and McHugh, B. (2011).  http://hdl.handle.net/10793/635 
No. 39. Chemical Residue in Irish Farmed Finfish, 2011. Glynn, D., McGovern, E., 
Slattery, T., Ó Conchubhair, D., Toomey, M., Kelly, C., Reid, A. and Moffat, R. (2013). 
http://hdl.handle.net/10793/876 
No. 40. Chemical Residues in Irish Farmed Finfish, 2012-2014.Glynn, D., Kelly, C., 
Moffat, R., Reid, A., Toomey, M., O’Hea, L., Elliott, M., Hickey, C., Geary, M., Ruane, 
N., and McGovern, E. (2015). http://hdl.handle.net/10793/1093 
No. 41. Proceedings of the 11th Irish Shellfish Safety Workshop (2020) 
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